Cargando…

Serum Contactin-1 in CIDP: A Cross-Sectional Study

OBJECTIVE: To investigate whether serum levels of contactin-1, a paranodal protein, correlate with paranodal injury as seen in patients with CIDP with antibodies targeting the paranodal region. METHODS: Serum contactin-1 levels were measured in 187 patients with CIDP and 222 healthy controls. Parano...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieske, Luuk, Martín-Aguilar, Lorena, Fehmi, Janev, Lleixà, Cinta, Koel-Simmelink, Marleen J.A., Chatterjee, Madhurima, van Lierop, Zoë, Killestein, Joep, Verhamme, Camiel, Querol, Luis, Rinaldi, Simon, Teunissen, Charlotte E., Eftimov, Filip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293285/ https://www.ncbi.nlm.nih.gov/pubmed/34285092 http://dx.doi.org/10.1212/NXI.0000000000001040

Ejemplares similares

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP
por: Querol, Luis, et al.
Publicado: (2021)

Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy
por: Amaador, Karima, et al.
Publicado: (2022)

Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis
por: Fehmi, Janev, et al.
Publicado: (2023)

Effect of monovalency on anti-contactin-1 IgG4
por: Taieb, Guillaume, et al.
Publicado: (2023)

Contactins in the central nervous system: role in health and disease
por: Chatterjee, Madhurima, et al.
Publicado: (2019)

Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype
por: Cortese, Andrea, et al.
Publicado: (2019)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab
por: van Kempen, Zoé L.E., et al.
Publicado: (2022)

Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child
por: Carrera-García, Laura, et al.
Publicado: (2019)

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
por: Eftimov, Filip, et al.
Publicado: (2014)

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial
por: van Veen, Robin, et al.
Publicado: (2022)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials
por: Wieske, Luuk, et al.
Publicado: (2021)

Isotyping paranodal antibodies in inflammatory neuropathies: One step closer to precision care
por: Lleixà, Cinta, et al.
Publicado: (2020)

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy
por: Eftimov, Filip, et al.
Publicado: (2020)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies
por: Chatterjee, Madhurima, et al.
Publicado: (2020)

Clinical outcome of CIDP one year after start of treatment: a prospective cohort study
por: Bus, S. R. M., et al.
Publicado: (2021)

Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study
por: Wieske, Luuk, et al.
Publicado: (2014)

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes
por: Feng, Yuan, et al.
Publicado: (2020)

Head and voice tremor improving with immunotherapy in an anti‐NF155 positive CIDP patient
por: Painous, Cèlia, et al.
Publicado: (2018)

Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Querol, Luis, et al.
Publicado: (2020)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
por: Querol, Luis, et al.
Publicado: (2015)

The Misdiagnosis of CIDP: A Review
por: Allen, Jeffrey A.
Publicado: (2020)

Treatment Approaches for Atypical CIDP
por: Menon, Deepak, et al.
Publicado: (2021)

Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons
por: Ramanathan, Sudarshini, et al.
Publicado: (2021)

Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients
por: Bridel, Claire, et al.
Publicado: (2017)

No Evidence for Association of Autism with Rare Heterozygous Point Mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins
por: Murdoch, John D., et al.
Publicado: (2015)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

CIDP mimics: a case series
por: Moshe-Lilie, Orly, et al.
Publicado: (2021)

Implication of Contactins in Demyelinating Pathologies
por: Kalafatakis, Ilias, et al.
Publicado: (2021)

Long-term tactile hypersensitivity after nerve crush injury in mice is characterized by the persistence of intact sensory axons
por: Kim, Hyoung Woo, et al.
Publicado: (2023)

Early Prediction of Intensive Care Unit–Acquired Weakness Using Easily Available Parameters: A Prospective Observational Study
por: Wieske, Luuk, et al.
Publicado: (2014)

Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study
por: Wieske, Luuk, et al.
Publicado: (2015)

Assessment of intensive care unit‐acquired weakness in young and old mice: An E. coli septic peritonitis model
por: Witteveen, Esther, et al.
Publicado: (2015)

Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
por: Witteveen, Esther, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s2rv8mi5jnok4eedgl7hgoar0l